Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1478)	10/6/1998 10:56:00 PM
From: wolfdog2	Respond to of 2173

Rudy, the data didn't look marginal to me with the exception of the infamous P3 trial. On what do you base your statement? Can you be specific? Ken

To: Rudy Saucillo who wrote (1478)	10/7/1998 10:02:00 PM
From: arnie h	Read Replies (1) \| Respond to of 2173

Rudy: Thanks for your comment. I have to say, I read the public clinical data rather carefully and came to a different conclusion than the one you expressed. As you point out, the next round of results should tell the story. No question, this is a 'bet the farm' situation for AMLN. Fortunately, I don't have a farm to bet but did put a few bucks into this one so its not a 'bet the farm' situation for me. I'll probably be betting on the Breeder's Cup races also. Arnie